Related Experiment Video
Updated: Jul 8, 2026

Tracking Drug-induced Changes in Receptor Post-internalization Trafficking by Colocalizational Analysis
Published on: July 3, 2015
Agonist-specific regulation of mu-opioid receptor desensitization and recovery from desensitization
Michael S Virk1, John T Williams
1Vollum Institute, L474, Oregon Health Sciences University, 3181 SW Sam Jackson Park Road, Portland, OR 97239. williamj@ohsu.edu.
Abstract:
Agonist-selective actions of opioids on the desensitization of mu-opioid receptors (MORs) have been well characterized, but few if any studies have examined agonist-dependent recovery from desensitization. The outward potassium current induced by several opioids was studied using whole-cell voltage-clamp recordings in locus ceruleus neurons. A brief application of the irreversible opioid antagonist beta-chlornaltrexamine (beta-CNA) was applied immediately after treatment of slices with saturating concentrations of opioid agonists. This approach permitted the measurement of desensitization and recovery from desensitization using multiple opioid agonists, including [Met](5)enkephalin (ME), [d-Ala(2),N-Me-Phe(4),Gly(5)-ol]-enkephalin (DAMGO), etorphine, fentanyl, methadone, morphine, morphine-6-glucuronide, oxycodone, and oxymorphone. The results indicate that desensitization protects receptors from irreversible antagonism with beta-CNA. The amount of desensitization was measured as the decrease in current during a 10-min application of a saturating agonist concentration and was a good predictor of the extent of receptor protection from irreversible inactivation with beta-CNA. After desensitization with ME or DAMGO and treatment with beta-CNA, there was an initial profound inhibition of MOR-induced current that recovered significantly after 45 min. There was, however, no recovery of MOR-mediated current with time after treatment with agonists that did not cause desensitization, such as oxycodone. These results demonstrate that desensitization prevents irreversible inactivation of receptors by beta-CNA.
Insights
Opioid receptor desensitization protects mu-opioid receptors (MORs) from irreversible inactivation. Recovery from desensitization depends on the specific opioid agonist used, revealing agonist-dependent mechanisms.
Area of Science:
- Neuroscience
- Pharmacology
- Molecular Biology
Background:
- Mu-opioid receptor (MOR) desensitization is well-studied, but agonist-dependent recovery is not.
- Opioid actions on MORs involve complex signaling pathways.
- Understanding MOR regulation is crucial for pain management.
Purpose of the Study:
- To investigate agonist-dependent recovery from mu-opioid receptor desensitization.
- To determine if receptor desensitization influences irreversible antagonism.
- To explore the role of desensitization in preventing irreversible inactivation of MORs.
Main Methods:
- Whole-cell voltage-clamp recordings in locus ceruleus neurons.
- Application of various opioid agonists and the irreversible antagonist beta-chlornaltrexamine (beta-CNA).
- Measurement of outward potassium current to assess desensitization and recovery.
Main Results:
- Receptor desensitization protected MORs from irreversible antagonism by beta-CNA.
- Agonists causing desensitization (ME, DAMGO) allowed significant recovery of MOR-mediated current after beta-CNA treatment.
- Agonists not causing desensitization (e.g., oxycodone) showed no recovery of MOR-mediated current.
Conclusions:
- Opioid receptor desensitization is a protective mechanism against irreversible inactivation.
- The recovery from desensitization is dependent on the specific opioid agonist.
- These findings highlight the complex, agonist-selective regulation of MOR signaling.
Related Concept Videos
Opioid Receptors: Overview
Analgesia and Pain Management
GPCR Desensitization
Drug-Receptor Interaction: Agonist
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous ligand's action.
Opioid Analgesics: Synthetic and Semisynthetic Opioids
Opioid Analgesics: Morphine and Other Natural Cogeners

